Jason Davies, MD,PhD (@jmdaviesmdphd) 's Twitter Profile
Jason Davies, MD,PhD

@jmdaviesmdphd

Brains, big data, bikes, and snow
Alum @Stanford, @StanfordMed, @NeurosurgUCSF
@UB_Neurosurgery Vascular and Skullbase Neurosurgery and Biomedical Informatics

ID: 2168935430

linkhttp://www.ubns.com calendar_today01-11-2013 19:04:34

1,1K Tweet

1,1K Followers

655 Following

AshuJadhav (@ashupjadhav) 's Twitter Profile Photo

Intra‐arterial Selective Bevacizumab Administration in the Middle Meningeal Artery for Chronic Subdural Hematoma: An Early Experience in 12 Hemispheres | Stroke: Vascular and Interventional Neurology ahajournals.org/doi/10.1161/SV… Stroke: Vascular and Interventional Neurology Stroke AHA/ASA SVIN

Intra‐arterial Selective Bevacizumab Administration in the Middle Meningeal Artery for Chronic Subdural Hematoma: An Early Experience in 12 Hemispheres | Stroke: Vascular and Interventional Neurology ahajournals.org/doi/10.1161/SV… <a href="/SVINJournal/">Stroke: Vascular and Interventional Neurology</a> <a href="/StrokeAHA_ASA/">Stroke AHA/ASA</a> <a href="/svinsociety/">SVIN</a>
Nurose Karim (@nurosekarim) 's Twitter Profile Photo

Late breaking session: MMAE for SDH 🔑 Headache- most common symptom 🔑 Midline shift More in the surgical arm 🔑 Burr hole > craniectomy 🔑 Microcather mostly placed distally 🔑 Odds ratio favors MMAE with statistical significance in surgical arm #SVIN24 SVIN

Late breaking session:
MMAE for SDH
🔑  Headache- most common symptom 
🔑 Midline shift More in the surgical arm
🔑 Burr hole &gt; craniectomy 
🔑 Microcather mostly placed distally 
🔑 Odds ratio favors MMAE with statistical significance in surgical arm 
#SVIN24 <a href="/svinsociety/">SVIN</a>
Thanh Lam "Lance" Tran (@lance_tran_) 's Twitter Profile Photo

ANSAAR RAI #SVIN24 kicks off with MEMBRANE - Eval efficacy/safety of +MMAE in cSDH s/p surg or SOC med mngt. 🔑Favors adjunct MMAE, signif in surgical population, not reached in med mngt cohort 👴Positive trend in the vulnerable population ≥75yo (a growing demographic in US)

<a href="/Ansaar_Rai/">ANSAAR RAI</a> #SVIN24 kicks off with MEMBRANE - Eval efficacy/safety of +MMAE in cSDH s/p surg or SOC med mngt. 

🔑Favors adjunct MMAE, signif in surgical population, not reached in med mngt cohort
👴Positive trend in the vulnerable population ≥75yo (a growing demographic in US)
Thanh Lam "Lance" Tran (@lance_tran_) 's Twitter Profile Photo

Peter Kan introduces the CHESS study at #SVIN24, a new RCT focused on moderately symptomatic pts (note inclusion criteria) investigating particle embolization for cSDH as stand-alone treatment.

<a href="/PeterKa80460001/">Peter Kan</a> introduces the CHESS study at #SVIN24, a new RCT focused on moderately symptomatic pts (note inclusion criteria) investigating particle embolization for cSDH as stand-alone treatment.
SVIN (@svinsociety) 's Twitter Profile Photo

⭐️Clinical Trial Updates⭐️ This week continues to be busy for the MMA #embolization trials for #SDH MEMBRANE results so far show a + treatment effect of MMAE compared to the non surgical cohort

⭐️Clinical Trial Updates⭐️

This week continues to be busy for the MMA #embolization trials for #SDH

MEMBRANE results so far show a + treatment effect of MMAE compared to the non surgical cohort
NEJM (@nejm) 's Twitter Profile Photo

Original Article: Adjunctive Middle Meningeal Artery Embolization for Subdural Hematoma (EMBOLISE) nej.md/3Zhbmol Editorial: Middle Meningeal Artery Embolization and Nonacute Subdural Hematoma nej.md/4fRauMv #Neurology

Original Article: Adjunctive Middle Meningeal Artery Embolization for Subdural Hematoma (EMBOLISE) nej.md/3Zhbmol 

Editorial: Middle Meningeal Artery Embolization and Nonacute Subdural Hematoma nej.md/4fRauMv 

#Neurology
NEJM (@nejm) 's Twitter Profile Photo

In patients with chronic subdural hematoma, the incidence of recurrence or progression remains high despite standard care. The effect of adding middle meningeal artery embolization to treatment is unclear. Research findings are summarized in a video. nej.md/3YX433L

In patients with chronic subdural hematoma, the incidence of recurrence or progression remains high despite standard care. The effect of adding middle meningeal artery embolization to treatment is unclear. Research findings are summarized in a video. nej.md/3YX433L
NEJM (@nejm) 's Twitter Profile Photo

Original Article: Middle Meningeal Artery Embolization for Nonacute Subdural Hematoma (MAGIC-MT) nej.md/3UZm6oM Editorial: Middle Meningeal Artery Embolization and Nonacute Subdural Hematoma nej.md/4fRauMv #Neurology

Original Article: Middle Meningeal Artery Embolization for Nonacute Subdural Hematoma (MAGIC-MT) nej.md/3UZm6oM 

Editorial: Middle Meningeal Artery Embolization and Nonacute Subdural Hematoma nej.md/4fRauMv 

#Neurology
NEJM (@nejm) 's Twitter Profile Photo

In the EMBOLISE trial, researchers assessed whether adding middle meningeal artery embolization to surgery reduces the risk of reoperation for recurrence or progression among patients with subacute or chronic subdural hematoma. Full trial results: nej.md/3Zhbmol

In the EMBOLISE trial, researchers assessed whether adding middle meningeal artery embolization to surgery reduces the risk of reoperation for recurrence or progression among patients with subacute or chronic subdural hematoma. Full trial results: nej.md/3Zhbmol
Jason Davies, MD,PhD (@jmdaviesmdphd) 's Twitter Profile Photo

Complex reconstruction of R carotid occlusion. Utilizing all to tools in the toolbox - symptomatic R carotid occlusion, failed traditional endo recanalization, failed CTO repair, failed carotid endarterectomy - enter the dual trained vascular neurosurgeon for hybrid endopass

Jason Davies, MD,PhD (@jmdaviesmdphd) 's Twitter Profile Photo

Young woman, followed for years with steadily progressive midbrain cavmal enlargement. Now reaches pial surface anteriorly. Quicktome to visualize tracts for safe entry between motor fibers and 3rd nerve nucleus. UB Neurosurgery (UBNS) UBNS Vascular Jacobs Institute | Nonprofit Med-Tech

NEJM (@nejm) 's Twitter Profile Photo

Presented at #ISC25: In the ESCAPE-MeVO trial involving patients with ischemic stroke due to medium-vessel occlusion, thrombectomy within 12 hours did not lead to a better functional outcome and lower mortality at 90 days than usual care. Full trial results:

Presented at #ISC25:

In the ESCAPE-MeVO trial involving patients with ischemic stroke due to medium-vessel occlusion, thrombectomy within 12 hours did not lead to a better functional outcome and lower mortality at 90 days than usual care. Full trial results:
Nanthiya Sujijantarat, MD (@sujijantaratmd) 's Twitter Profile Photo

Our JNIS paper on pre-op IMA embolization for TMJ replacement surgery is out! 👀 Watch this video overview or click the link below for full text 📚 A big thank you to the senior author Dr. Rabinov, MGH OMFS team, and our NSGY/NIR co‑authors for their invaluable contributions!

Stroke AHA/ASA (@strokeaha_asa) 's Twitter Profile Photo

As Dr Nerissa Ko mentioned, a stroke patient survivor reminded us why we do what we do. Dr William Mack with a grateful stroke patient who recovered speech after a healed carotid dissection. #ISC25

As Dr Nerissa Ko mentioned, a stroke patient survivor reminded us why we do what we do. Dr William Mack with a grateful stroke patient who recovered speech after a healed carotid dissection. #ISC25
Jason Davies, MD,PhD (@jmdaviesmdphd) 's Twitter Profile Photo

Embo for sdh works, but questions remain. Grateful to #OCIN2025 杨朋飞 @左乔 for invitation to discuss. Large-scale multinational collaborations will always get us to the right answers faster than keeping to ourselves. UB Neurosurgery (UBNS) Adnan H. Siddiqui, MD Jacobs Institute | Nonprofit Med-Tech

Embo for sdh works, but questions remain.  Grateful to #OCIN2025 <a href="/PengfeiYang/">杨朋飞</a> @左乔  for invitation to discuss. Large-scale multinational collaborations will always get us to the right answers faster than keeping to ourselves.  <a href="/UB_Neurosurgery/">UB Neurosurgery (UBNS)</a> <a href="/_AdnanSiddiqui/">Adnan H. Siddiqui, MD</a> <a href="/JacobsInstitute/">Jacobs Institute | Nonprofit Med-Tech</a>